Cobalt Blues: A New Complication of Hydroxocobalamin Therapy for Vasopressor-Resistant Vasoplegia in Patients Treated With Chronic Renal Replacement Therapy?

J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3406-3408. doi: 10.1053/j.jvca.2019.08.033. Epub 2019 Aug 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cobalt
  • Humans
  • Hydroxocobalamin
  • Renal Replacement Therapy
  • Vasoconstrictor Agents
  • Vasoplegia*

Substances

  • Vasoconstrictor Agents
  • Cobalt
  • Hydroxocobalamin